{"database": "openregs", "table": "documents", "rows": [["FDA-2001-D-0219-0015", "FDA", "FDA-2001-D-0219", "Use of Data Monitoring Committees in Clinical Trials; Draft Guidance for Industry; Availability; Agency\nInformation Collection Activities; Proposed Collection; Comment Request", "Notice", "Notice of Availability", "2024-02-13T05:00:00Z", 2024, 2, null, null, "2024-02-13T14:42:27Z", "2024-02849", 0, 0, "0900006486404168"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2001-D-0219-0015"], "units": {}, "query_ms": 0.331308925524354, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}